Importantly, increased scrutiny of the interaction between IPAs, other risk factors, and oncogene activity in the premalignant setting has the potential to yield insights valuable for pancreatic cancer prevention and cancer interception, and merits further investigation. Here, HIF3A is linked to cancer.